FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

MDIC Device External Evidence Framework

The Medical Device Innovation Consortium publishes its framework on external evidence methods for medical devices based on input from FDA and other st...

Human Drugs

Simulations Plus Finishes FDA Project

Simulations Plus completes an FDA-funded project for a model-integrated design for bioequivalence studies in long-acting injectable drugs.

Human Drugs

FDA Wants Authority to Require Superiority Data in NDAs

FDA commissioner Robert Califf says the agency is considering asking Congress for additional authority to have the option of requiring drug sponsors ...

Human Drugs

BIO Comments on Pediatric Cancer Drug Docket

The Biotechnology Innovation Organization suggests ways for FDA to create a conceptual framework to inform decision-making for pediatric cancer drugs.

Biologics

Moderna Seeks Vaccine EUA for Kids 6 Months to 6 Years

Moderna is asking FDA for an emergency use authorization for its Covid-19 vaccine in children aged 6 months to 6 years old.

Human Drugs

Lillys Tirzepatide Meets Trial Weight Loss Endpoints

Lilly says its investigational weight-loss drug tirzepatide met all endpoints in the 72-week SURMOUNT-1 trial.

Human Drugs

FDA Lifts Hold on Pfizer Duchenne Gene Therapy

FDA lifts a clinical hold on Pfizers mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory patients with Duchenne muscular dystrop...

Medical Devices

Risk Documents Key in Device Design: Column

Retired Ethicon quality engineer Eric Hinrichs says medical device project design teams must document all risk assessments and how the risks have been...

Human Drugs

McKinsey FDA Contract Under Fire at Hearing

A House Committee on Oversight and Reform hearing sharply criticizes consulting firm McKinsey and Co. for its role in advising Purdue Pharm during the...

Human Drugs

Current Merger Enforcement is Working: PhRMA

PhRMA cites FDA statistics to support its position that the Federal Trade Commission and Department of Justice dont need new ways to evaluate how drug...